Skip to main content
. 2022 Aug 30;13:1005115. doi: 10.3389/fimmu.2022.1005115

Figure 1.

Figure 1

Immune model of the imbalance between Type 17 T-cells (T17 cells) and regulatory immune cell subsets in psoriasis with biologic agents targeting the IL-23/T17 cell axis.